Bright Lights EP31: Ron Eibensteiner

Mr. Eibensteiner has been President of Wyncrest Capital, Inc., an investment company for early-stage technology companies in the area of telecommunications, medical devices and software since 1993. He has served on the Board of Directors for Miromatrix since 2010. Mr. Eibensteiner’s past investment activities include: co-founder of Diametrics Medical, Inc., a manufacturer of blood gas diagnostic systems; a principal investor and Board member of OnHealth Network Company, a web-based publisher of health and wellness information which was later merged with WebMD; principal investor and Board member of BigCharts, Inc., a provider of financial internet content, until its sale to Dow Jones/MarketWatch in June 1999; Chairman of the Board of Prodea Software Corporation, a data-warehousing software company, until its sale to Platinum Technology, Inc.; and principal investor and Board of Director member of Travanti Pharma Inc, a specialty drug delivery firm, until its sale to Teikoku Pharmaceutical in May of 2009. Mr. Eibensteiner also served as a member of the Board of Stellant Software (Nasdaq: STEL) from 1996 until 2001. In 1983, he co-founded Arden Medical Systems and served as its Chief Financial Officer until its sale to Johnson & Johnson in 1987.  Mr. Eibensteiner currently serves as Chairman of the Center of the American Experiment, a public policy group in Minnesota dedicated to solving some of our nation’s most pressing issues and holds a Bachelor of Science degree in political science from the University of Minnesota.  He also serves on the Board of TakeCharge Minnesota, an organization that empowers people to take charge of their lives and not to depend on a group, agency, or government for their well-being. TakeCharge Minnesota strives to unite Americans regardless of background toward a shared history and common set of beliefs and celebrates the successes of all who have achieved the American dream while encouraging people still working to achieve it.